US Patent Issued to Regulus Therapeutics on Feb. 24 for "Methods and compositions for treatment of polycystic kidney disease" (California Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,750, issued on Feb. 24, was assigned to Regulus Therapeutics Inc. (San Diego).

"Methods and compositions for treatment of polycystic kidney disease" was invented by Denis Drygin (San Diego), Garth A. Kinberger (San Diego) and Edmund Chun Yu Lee (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for the treatment of polycystic kidney disease, including autosomal dominant polycystic kidney disease, using modified oligonucleotides targeted to miR-17."

The patent was filed on Feb. 12, 2025, under Application No. 19/052,052.

*For further information, including images, charts and tables, please visit: http://patft.uspt...